Skip to main content
Caplight Logo









Valthos

Valthos

Private
New York City, New YorkHealthcare & Life Scienceshttps://valthos.com/

Last Round

Early Stage

VC

Apr 1, 2026

Total Funding Raised

$30M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Valthos is a biotechnology and artificial intelligence company that develops software and AI systems to identify biological threats and design medical countermeasures.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Defense Tech, Drug Discovery, Medical AI, Threat Intelligence

Business Model

B2G

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

biodefensemedical countermeasure designbiological intelligencedefense techbiosecuritycomputational biologythreat intelligencedrug discoverymutational landscape analysisbio-surveillanceAI-driven softwarebiotech AIfrontier AIB2Gpandemic preparedness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valthos Comparables

Compare Valthos with similar companies based on industry and business-model similarity.

Valthos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Radical Numerics
76%
Red Queen Bio
74%
Perimeter Systems
72%

Valthos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCApr 1, 2026
SeedOct 29, 2025

Key People

Founding team and executive leadership

Kathleen McMahon

Co-Founder & CEO

Founding Team

Valthos Investors

Notable investors and investment history

Valthos investors
InvestorRounds
Founders FundSeed
Lux CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    Grew 27% QoQ from 11 to 14 employees.

  • Jul 28, 2026

    Grew 50% QoQ from 10 to 15 employees.

Recent news

Latest coverage and updates

  • is_developingSep 18, 2026

    Valthos Inc. is developing AI-based biodefense platform.

Valthos Filings

Explore SEC and related filing metadata, where available.

Valthos filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Valthos's valuation, stock price, and market status.

Is Valthos a public or private company?

Valthos is a private company.

What is the current stock price of Valthos?

Valthos is a private company with no public stock price. No recent secondary market data is available.

How much is Valthos worth (valuation)?

Valuation information for Valthos is not publicly available.

Can I buy Valthos stock?

Valthos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Valthos's last funding round?

Valthos's most recent funding round was Early Stage VC on April 1, 2026.

Who are the main investors in Valthos?

Key investors in Valthos include Founders Fund, Lux Capital.

Will Valthos IPO soon?

No public IPO plans have been announced for Valthos.

How can I track Valthos secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Valthos's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2024
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?